444 related articles for article (PubMed ID: 30725328)
1. Factors that impact the outcomes in testicular germ cell tumors in low-middle-income countries.
Saju SV; Radhakrishnan V; Ganesan TS; Dhanushkodi M; Raja A; Selvaluxmy G; Sagar TG
Med Oncol; 2019 Feb; 36(3):28. PubMed ID: 30725328
[TBL] [Abstract][Full Text] [Related]
2. Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors.
Funt SA; Patil S; Feldman DR; Motzer RJ; Bajorin DF; Sheinfeld J; Tickoo SK; Reuter VE; Bosl GJ
J Clin Oncol; 2019 Sep; 37(26):2329-2337. PubMed ID: 31233353
[TBL] [Abstract][Full Text] [Related]
3. Conditional Survival of Patients With Metastatic Testicular Germ Cell Tumors Treated With First-Line Curative Therapy.
Ko JJ; Bernard B; Tran B; Li H; Asif T; Stukalin I; Lee M; Day D; Alimohamed N; Sweeney CJ; Bedard PL; Heng DY
J Clin Oncol; 2016 Mar; 34(7):714-20. PubMed ID: 26786931
[TBL] [Abstract][Full Text] [Related]
4. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ
Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612
[TBL] [Abstract][Full Text] [Related]
5. Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium.
Bührer E; D'Haese D; Daugaard G; de Wit R; Albany C; Tryakin A; Fizazi K; Stahl O; Gietema JA; De Giorgi U; Cafferty FH; Hansen AR; Tandstad T; Huddart RA; Necchi A; Sweeney CJ; Garcia-Del-Muro X; Heng DYC; Lorch A; Chovanec M; Winquist E; Grimison P; Feldman DR; Terbuch A; Hentrich M; Bokemeyer C; Negaard H; Fankhauser C; Shamash J; Vaughn DJ; Sternberg CN; Heidenreich A; Collette L; Gillessen S; Beyer J
Eur J Cancer; 2024 May; 202():114042. PubMed ID: 38564927
[TBL] [Abstract][Full Text] [Related]
6. Low Survival in Poor Prognosis Metastatic Germ Cell Cancer in Belarus.
Rolevich AI; Borodin DM; Rabcheuski AN; Ivanitskaya TA; Semenov SA; Artsiushkevich LV; Sukalinskaya AV; Zhavrid EA; Krasny SA; Konoplya NE; Polyakov SL
JCO Glob Oncol; 2021 Jan; 7():63-71. PubMed ID: 33434070
[TBL] [Abstract][Full Text] [Related]
7. Impact of primary metastatic bone disease in germ cell tumors: results of an International Global Germ Cell Tumor Collaborative Group G3 Registry Study.
Oing C; Oechsle K; Necchi A; Loriot Y; De Giorgi U; Fléchon A; Daugaard G; Fedyanin M; Faré E; Bokemeyer C
Ann Oncol; 2017 Mar; 28(3):576-582. PubMed ID: 27993806
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
[TBL] [Abstract][Full Text] [Related]
9. Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG).
Germà-Lluch JR; Garcia del Muro X; Maroto P; Paz-Ares L; Arranz JA; Gumà J; Alba E; Sastre J; Aparicio J; Fernández A; Barnadas A; Terrassa J; Sáenz A; Almenar D; López-Brea M; Climent MA; Sánchez MA; Lasso de la Vega R; Berenguer G; Pérez X;
Eur Urol; 2002 Dec; 42(6):553-62; discussion 562-3. PubMed ID: 12477650
[TBL] [Abstract][Full Text] [Related]
10. Multicenter Database of Patients with Germ-Cell Tumors: A Latin American Cooperative Oncology Group Registry (LACOG 0515).
Bastos DA; Gongora ABL; Dzik C; Jardim DL; Piva M; Carcano FM; Bertollo G; Trindade K; Fontes MS; Soares A; Reinert T; De Cassia Costamilan R; Villarroel RU; Watarai G; Gazola AA; Preto DDA; Mutti H; Bonalumi Dos Santos M; Mariano RC; Binotto M; Carvalho MM; Oliveira VPDC; Gomes R; Rebelatto TF; Schutz FA; Smaletz O; Fay AP
Clin Genitourin Cancer; 2023 Jun; 21(3):e104-e113. PubMed ID: 36509612
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of male seminomatous and nonseminomatous germ cell tumors and response to first-line chemotherapy from a tertiary cancer center in India.
Joshi A; Zanwar S; Shetty N; Patil V; Noronha V; Bakshi G; Prakash G; Menon S; Prabhash K
Indian J Cancer; 2016; 53(2):313-316. PubMed ID: 28071636
[TBL] [Abstract][Full Text] [Related]
12. Survival outcomes of adolescent and adult patients with non-seminomatous testicular germ-cell tumors: A population-based study.
Amini A; Waxweiler TV; Maroni PD; Kessler ER; Cost CR; Greffe BS; Garrington TP; Liu AK; Cost NG
J Pediatr Urol; 2016 Dec; 12(6):405.e1-405.e9. PubMed ID: 27544905
[TBL] [Abstract][Full Text] [Related]
13. [A clinical study of testicular tumors].
Matsuki H; Ozono S; Arai K; Saka M; Cho M; Nakagawa Y; Kaneko Y; Yoshida K; Okamoto S; Maruyama Y
Hinyokika Kiyo; 1988 Oct; 34(10):1757-65. PubMed ID: 2854363
[TBL] [Abstract][Full Text] [Related]
14. Multimodality treatment outcome in patients with primary malignant mediastinal germ cell tumor in adults.
Biswas B; Dabkara D; Sengupta M; Ganguly S; Ghosh J; Arunsingh S M; Sen S
Cancer Rep (Hoboken); 2021 Feb; 4(1):e1306. PubMed ID: 33029924
[TBL] [Abstract][Full Text] [Related]
15. Primary mediastinal germ cell tumours with high prevalence of somatic malignancy: An experience from a single tertiary care oncology centre.
Beg A; Kumar R; Sahay A; Janu A; Joshi A; Noronha V; Prabhash K; Karimundackal G; Jiwnani S; Agarwal JP; Pramesh CS
Ann Diagn Pathol; 2021 Aug; 53():151763. PubMed ID: 34111707
[TBL] [Abstract][Full Text] [Related]
16. Histologic type, staging, and distribution of germ cell tumors in Korean adults.
Park DS; Chung MK; Chung JI; Ahn HJ; Lee ES; Choi HY; Yoon DK; Cheon J; Hong SJ; Lee YG; Yoon SM; Kim WJ; Kim HJ; Ryu SB; Ro JY
Urol Oncol; 2008; 26(6):590-4. PubMed ID: 18367106
[TBL] [Abstract][Full Text] [Related]
17. Clinical profile, treatment and survival outcome of testicular tumors: a pakistani perspective.
Bhatti AB; Ahmed I; Ghauri RK; Saeed Q; Mir K
Asian Pac J Cancer Prev; 2014; 15(1):277-80. PubMed ID: 24528039
[TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics and Treatment Outcomes of Patients With Advanced Germ Cell Tumor Treated at a Tertiary Cancer Center in Brazil.
Vasconcellos VF; Bastos DA; Pereira AAL; Watarai GY; Pereira BR; de Godoy A; Almeida-Silva J; Muniz DQB; Guglielmetti GB; Nahas WC; Dzik C
J Glob Oncol; 2019 Feb; 5():1-8. PubMed ID: 30779600
[TBL] [Abstract][Full Text] [Related]
19. A comparison of pediatric, adolescent, and adult testicular germ cell malignancy.
Cost NG; Lubahn JD; Adibi M; Romman A; Wickiser JE; Raj GV; Sagalowsky AI; Margulis V
Pediatr Blood Cancer; 2014 Mar; 61(3):446-51. PubMed ID: 24106160
[TBL] [Abstract][Full Text] [Related]
20. Survival of metastatic germ cell cancer patients assessed by international germ cell consensus classification in Japan.
Shintaku I; Satoh M; Okajima E; Fujimoto H; Kamoto T; Ogawa O; Kawai K; Akaza H; Tsukamoto T; Naito S; Miki T; Arai Y
Jpn J Clin Oncol; 2008 Apr; 38(4):281-7. PubMed ID: 18321891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]